-
The R-Vessel-X Project
Authors:
Abir Affane,
Mohamed Amine Chetoui,
Jonas Lamy,
Guillaume Lienemann,
Raphaël Peron,
P. Beaurepaire,
Guillaume Dollé,
Marie-Ange Lèbre,
Benoit Magnin,
Odyssée Merveille,
Mathilde Morvan,
Phuc Ngo,
Thibault Pelletier,
Hugo Rositi,
Stéphanie Salmon,
Julien Finet,
Bertrand Kerautret,
Nicolas Passat,
Antoine Vacavant
Abstract:
1) Objectives: This technical report presents a synthetic summary and the principal outcomes of the project R-Vessel-X ("Robust vascular network extraction and understanding within hepatic biomedical images") funded by the French Agence Nationale de la Recherche, and developed between 2019 and 2023. 2) Material and methods: We used datasets and tools publicly available such as IRCAD, Bullitt or Va…
▽ More
1) Objectives: This technical report presents a synthetic summary and the principal outcomes of the project R-Vessel-X ("Robust vascular network extraction and understanding within hepatic biomedical images") funded by the French Agence Nationale de la Recherche, and developed between 2019 and 2023. 2) Material and methods: We used datasets and tools publicly available such as IRCAD, Bullitt or VascuSynth toobtain real or synthetic angiographic images. The main contributions lie in the field of 3D angiographic image analysis: filtering, segmentation, modeling and simulation, with a specific focus on the liver. 3) Results: We paid a particular attention to open-source software diffusion of the developed methods, by means of 3D Slicer plugins for the liver anatomy segmentation (SlicerRVXLiverSegmentation) and vesselness filtering (Slicer-RVXVesselnessFilters), and an online demo for the generation of synthetic and realistic vessels in 2D and 3D (OpenCCO). 4) Conclusion: The R-Vessel-X project provided extensive research outcomes, covering various topics related to 3D angiographic image analysis, such as filtering, segmentation, modeling and simulation. We also developed open-source and free softwares so that the research communities in biomedical engineering can use these results in their future research.
△ Less
Submitted 17 January, 2025;
originally announced January 2025.
-
A randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management
Authors:
Abdelmalek Mouazer,
Sophie Dubois,
Romain Léguillon,
Nada Boudegzdame,
Thibaud Levrard,
Yoann Le Bars,
Christian Simon,
Brigitte Séroussi,
Julien Grosjean,
Romain Lelong,
Catherine Letord,
Stéfan Darmoni,
Karima Sedki,
Pierre Meneton,
Rosy Tsopra,
Hector Falcoff,
Jean-Baptiste Lamy
Abstract:
Background: Medication review is a structured interview of the patient, performed by the pharmacist and aimed at optimizing drug treatments. In practice, medication review is a long and cognitively-demanding task that requires specific knowledge. Clinical practice guidelines have been proposed, but their application is tedious. Methods: We designed ABiMed, a clinical decision support system for me…
▽ More
Background: Medication review is a structured interview of the patient, performed by the pharmacist and aimed at optimizing drug treatments. In practice, medication review is a long and cognitively-demanding task that requires specific knowledge. Clinical practice guidelines have been proposed, but their application is tedious. Methods: We designed ABiMed, a clinical decision support system for medication reviews, based on the implementation of the STOPP/START v2 guidelines and on the visual presentation of aggregated drug knowledge using tables, graphs and flower glyphs. We evaluated ABiMed with 39 community pharmacists during a randomized simulation trial, each pharmacist performing a medication review for two fictitious patients without ABiMed, and two others with ABiMed. We recorded the problems identified by the pharmacists, the interventions proposed, the response time, the perceived usability and the comments. Pharmacists' medication reviews were compared to an expert-designed gold standard. Results: With ABiMed, pharmacists found 1.6 times more relevant drug-related problems during the medication review (p=1.1e-12) and proposed better interventions (p=9.8e-9), without needing more time (p=0.56). The System Usability Scale score is 82.7, which is ranked "excellent". In their comments, pharmacists appreciated the visual aspect of ABiMed and its ability to compare the current treatment with the proposed one. A multifactor analysis showed no difference in the support offered by ABiMed according to the pharmacist's age or sex, in terms of percentage of problems identified or quality of the proposed interventions. Conclusions: The use of an intelligent and visual clinical decision support system can help pharmacists when they perform medication reviews. Our main perspective is the validation of the system in clinical conditions.
△ Less
Submitted 3 September, 2024;
originally announced September 2024.
-
Impact on clinical guideline adherence of Orient-COVID, a CDSS based on dynamic medical decision trees for COVID19 management: a randomized simulation trial
Authors:
Mouin Jammal,
Antoine Saab,
Cynthia Abi Khalil,
Charbel Mourad,
Rosy Tsopra,
Melody Saikali,
Jean-Baptiste Lamy
Abstract:
Background: The adherence of clinicians to clinical practice guidelines is known to be low, including for the management of COVID-19, due to their difficult use at the point of care and their complexity. Clinical decision support systems have been proposed to implement guidelines and improve adherence. One approach is to permit the navigation inside the recommendations, presented as a decision tre…
▽ More
Background: The adherence of clinicians to clinical practice guidelines is known to be low, including for the management of COVID-19, due to their difficult use at the point of care and their complexity. Clinical decision support systems have been proposed to implement guidelines and improve adherence. One approach is to permit the navigation inside the recommendations, presented as a decision tree, but the size of the tree often limits this approach and may cause erroneous navigation, especially when it does not fit in a single screen. Methods: We proposed an innovative visual interface to allow clinicians easily navigating inside decision trees for the management of COVID-19 patients. It associates a multi-path tree model with the use of the fisheye visual technique, allowing the visualization of large decision trees in a single screen. To evaluate the impact of this tool on guideline adherence, we conducted a randomized controlled trial in a near-real simulation setting, comparing the decisions taken by medical students using Orient-COVID with those taken with paper guidelines or without guidance, when performing on six realistic clinical cases. Results: The results show that paper guidelines had no impact (p=0.97), while Orient-COVID significantly improved the guideline adherence compared to both other groups (p<0.0003). A significant impact of Orient-COVID was identified on several key points during the management of COVID-19: ordering troponin lab tests, prescribing anticoagulant and oxygen therapy. A multifactor analysis showed no difference between male and female participants. Conclusions: The use of an interactive decision tree for the management of COVID-19 significantly improved the clinician adherence to guidelines. Future works will focus on the integration of the system to electronic health records and on the adaptation of the system to other clinical conditions.
△ Less
Submitted 21 June, 2024;
originally announced July 2024.
-
ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management
Authors:
Abdelmalek Mouazer,
Romain Léguillon,
Nada Boudegzdame,
Thibaud Levrard,
Yoann Le Bars,
Christian Simon,
Brigitte Séroussi,
Julien Grosjean,
Romain Lelong,
Catherine Letord,
Stéfan Darmoni,
Matthieu Schuers,
Karima Sedki,
Sophie Dubois,
Hector Falcoff,
Rosy Tsopra,
Jean-Baptiste Lamy
Abstract:
Background: Polypharmacy, i.e. taking five drugs or more, is both a public health and an economic issue. Medication reviews are structured interviews of the patient by the community pharmacist, aiming at optimizing the drug treatment and deprescribing useless, redundant or dangerous drugs. However, they remain difficult to perform and time-consuming. Several clinical decision support systems were…
▽ More
Background: Polypharmacy, i.e. taking five drugs or more, is both a public health and an economic issue. Medication reviews are structured interviews of the patient by the community pharmacist, aiming at optimizing the drug treatment and deprescribing useless, redundant or dangerous drugs. However, they remain difficult to perform and time-consuming. Several clinical decision support systems were developed for helping clinicians to manage polypharmacy. However, most were limited to the implementation of clinical practice guidelines. In this work, our objective is to design an innovative clinical decision support system for medication reviews and polypharmacy management, named ABiMed.
Methods: ABiMed associates several approaches: guidelines implementation, but the automatic extraction of patient data from the GP's electronic health record and its transfer to the pharmacist, and the visual presentation of contextualized drug knowledge using visual analytics. We performed an ergonomic assessment and qualitative evaluations involving pharmacists and GPs during focus groups and workshops.
Results: We describe the proposed architecture, which allows a collaborative multi-user usage. We present the various screens of ABiMed for entering or verifying patient data, for accessing drug knowledge (posology, adverse effects, interactions), for viewing STOPP/START rules and for suggesting modification to the treatment. Qualitative evaluations showed that health professionals were highly interested by our approach, associating the automatic guidelines execution with the visual presentation of drug knowledge.
Conclusions: The association of guidelines implementation with visual presentation of knowledge is a promising approach for managing polypharmacy. Future works will focus on the improvement and the evaluation of ABiMed.
△ Less
Submitted 13 December, 2023;
originally announced December 2023.
-
Adaptive questionnaires for facilitating patient data entry in clinical decision support systems: Methods and application to STOPP/START v2
Authors:
Jean-Baptiste Lamy,
Abdelmalek Mouazer,
Karima Sedki,
Sophie Dubois,
Hector Falcoff
Abstract:
Clinical decision support systems are software tools that help clinicians to make medical decisions. However, their acceptance by clinicians is usually rather low. A known problem is that they often require clinicians to manually enter lots of patient data, which is long and tedious. Existing solutions, such as the automatic data extraction from electronic health record, are not fully satisfying,…
▽ More
Clinical decision support systems are software tools that help clinicians to make medical decisions. However, their acceptance by clinicians is usually rather low. A known problem is that they often require clinicians to manually enter lots of patient data, which is long and tedious. Existing solutions, such as the automatic data extraction from electronic health record, are not fully satisfying, because of low data quality and availability. In practice, many systems still include long questionnaire for data entry.
In this paper, we propose an original solution to simplify patient data entry, using an adaptive questionnaire, i.e. a questionnaire that evolves during user interaction, showing or hiding questions dynamically. Considering a rule-based decision support systems, we designed methods for translating the system's clinical rules into display rules that determine the items to show in the questionnaire, and methods for determining the optimal order of priority among the items in the questionnaire. We applied this approach to a decision support system implementing STOPP/START v2, a guideline for managing polypharmacy. We show that it permits reducing by about two thirds the number of clinical conditions displayed in the questionnaire. Presented to clinicians during focus group sessions, the adaptive questionnaire was found "pretty easy to use". In the future, this approach could be applied to other guidelines, and adapted for data entry by patients.
△ Less
Submitted 19 September, 2023;
originally announced September 2023.
-
A data science approach to drug safety: Semantic and visual mining of adverse drug events from clinical trials of pain treatments
Authors:
Jean-Baptiste Lamy
Abstract:
Clinical trials are the basis of Evidence-Based Medicine. Trial results are reviewed by experts and consensus panels for producing meta-analyses and clinical practice guidelines. However, reviewing these results is a long and tedious task, hence the meta-analyses and guidelines are not updated each time a new trial is published. Moreover, the independence of experts may be difficult to appraise. O…
▽ More
Clinical trials are the basis of Evidence-Based Medicine. Trial results are reviewed by experts and consensus panels for producing meta-analyses and clinical practice guidelines. However, reviewing these results is a long and tedious task, hence the meta-analyses and guidelines are not updated each time a new trial is published. Moreover, the independence of experts may be difficult to appraise. On the contrary, in many other domains, including medical risk analysis, the advent of data science, big data and visual analytics allowed moving from expert-based to fact-based knowledge. Since 12 years, many trial results are publicly available online in trial registries. Nevertheless, data science methods have not yet been applied widely to trial data. In this paper, we present a platform for analyzing the safety events reported during clinical trials and published in trial registries. This platform is based on an ontological model including 582 trials on pain treatments, and uses semantic web technologies for querying this dataset at various levels of granularity. It also relies on a 26-dimensional flower glyph for the visualization of the Adverse Drug Events (ADE) rates in 13 categories and 2 levels of seriousness. We illustrate the interest of this platform through several use cases and we were able to find back conclusions that were initially found during meta-analyses. The platform was presented to four experts in drug safety, and is publicly available online, with the ontology of pain treatment ADE.
△ Less
Submitted 17 April, 2021; v1 submitted 19 June, 2020;
originally announced June 2020.
-
Using graph transformation algorithms to generate natural language equivalents of icons expressing medical concepts
Authors:
Pascal Vaillant,
Jean-Baptiste Lamy
Abstract:
A graphical language addresses the need to communicate medical information in a synthetic way. Medical concepts are expressed by icons conveying fast visual information about patients' current state or about the known effects of drugs. In order to increase the visual language's acceptance and usability, a natural language generation interface is currently developed. In this context, this paper des…
▽ More
A graphical language addresses the need to communicate medical information in a synthetic way. Medical concepts are expressed by icons conveying fast visual information about patients' current state or about the known effects of drugs. In order to increase the visual language's acceptance and usability, a natural language generation interface is currently developed. In this context, this paper describes the use of an informatics method ---graph transformation--- to prepare data consisting of concepts in an OWL-DL ontology for use in a natural language generation component. The OWL concept may be considered as a star-shaped graph with a central node. The method transforms it into a graph representing the deep semantic structure of a natural language phrase. This work may be of future use in other contexts where ontology concepts have to be mapped to half-formalized natural language expressions.
△ Less
Submitted 26 September, 2014;
originally announced November 2014.
-
A semi-automatic semantic method for mapping SNOMED CT concepts to VCM Icons
Authors:
Jean-Baptiste Lamy,
Rosy Tsopra,
Alain Venot,
Catherine Duclos
Abstract:
VCM (Visualization of Concept in Medicine) is an iconic language for representing key medical concepts by icons. However, the use of this language with reference terminologies, such as SNOMED CT, will require the mapping of its icons to the terms of these terminologies. Here, we present and evaluate a semi-automatic semantic method for the mapping of SNOMED CT concepts to VCM icons. Both SNOMED CT…
▽ More
VCM (Visualization of Concept in Medicine) is an iconic language for representing key medical concepts by icons. However, the use of this language with reference terminologies, such as SNOMED CT, will require the mapping of its icons to the terms of these terminologies. Here, we present and evaluate a semi-automatic semantic method for the mapping of SNOMED CT concepts to VCM icons. Both SNOMED CT and VCM are compositional in nature; SNOMED CT is expressed in description logic and VCM semantics are formalized in an OWL ontology. The proposed method involves the manual mapping of a limited number of underlying concepts from the VCM ontology, followed by automatic generation of the rest of the mapping. We applied this method to the clinical findings of the SNOMED CT CORE subset, and 100 randomly-selected mappings were evaluated by three experts. The results obtained were promising, with 82 of the SNOMED CT concepts correctly linked to VCM icons according to the experts. Most of the errors were easy to fix.
△ Less
Submitted 3 December, 2013;
originally announced December 2013.
-
A generic system for critiquing physicians' prescriptions: usability, satisfaction and lessons learnt
Authors:
Jean-Baptiste Lamy,
Vahid Ebrahiminia,
Brigitte Seroussi,
Jacques Bouaud,
Christian Simon,
Madeleine Favre,
Hector Falcoff,
Alain Venot
Abstract:
Clinical decision support systems have been developed to help physicians to take clinical guidelines into account during consultations. The ASTI critiquing module is one such systems; it provides the physician with automatic criticisms when a drug prescription does not follow the guidelines. It was initially developed for hypertension and type 2 diabetes, but is designed to be generic enough for a…
▽ More
Clinical decision support systems have been developed to help physicians to take clinical guidelines into account during consultations. The ASTI critiquing module is one such systems; it provides the physician with automatic criticisms when a drug prescription does not follow the guidelines. It was initially developed for hypertension and type 2 diabetes, but is designed to be generic enough for application to all chronic diseases. We present here the results of usability and satisfaction evaluations for the ASTI critiquing module, obtained with GPs for a newly implemented guideline concerning dyslipaemia, and we discuss the lessons learnt and the difficulties encountered when building a generic DSS for critiquing physicians' prescriptions.
△ Less
Submitted 3 December, 2013;
originally announced December 2013.
-
Use of the C4.5 machine learning algorithm to test a clinical guideline-based decision support system
Authors:
Jean-Baptiste Lamy,
Anis Ellini,
Vahid Ebrahiminia,
Jean-Daniel Zucker,
Hector Falcoff,
Alain Venot
Abstract:
Well-designed medical decision support system (DSS) have been shown to improve health care quality. However, before they can be used in real clinical situations, these systems must be extensively tested, to ensure that they conform to the clinical guidelines (CG) on which they are based. Existing methods cannot be used for the systematic testing of all possible test cases. We describe here a new e…
▽ More
Well-designed medical decision support system (DSS) have been shown to improve health care quality. However, before they can be used in real clinical situations, these systems must be extensively tested, to ensure that they conform to the clinical guidelines (CG) on which they are based. Existing methods cannot be used for the systematic testing of all possible test cases. We describe here a new exhaustive dynamic verification method. In this method, the DSS is considered to be a black box, and the Quinlan C4.5 algorithm is used to build a decision tree from an exhaustive set of DSS input vectors and outputs. This method was successfully used for the testing of a medical DSS relating to chronic diseases: the ASTI critiquing module for type 2 diabetes.
△ Less
Submitted 3 December, 2013;
originally announced December 2013.
-
Superfluorescent emission in electrically pumped semiconductor laser
Authors:
D. L. Boiko,
X. Zeng,
T. Stadelmann,
S. Grossmann,
A. Hoogerwerf,
T. Weig,
U. T. Schwarz,
L. Sulmoni,
J. -M. Lamy,
N. Grandjean
Abstract:
We report superfluorescent (SF) emission in electrically pumped InGaN/InGaN QW lasers with saturable absorber. In particular, we observe a superlinear growth of the peak power of SF pulses with increasing amplitude of injected current pulses and attribute it to cooperative pairing of electron-hole (e-h) radiative recombinations. The phase transitions from amplified spontaneous emission to superflu…
▽ More
We report superfluorescent (SF) emission in electrically pumped InGaN/InGaN QW lasers with saturable absorber. In particular, we observe a superlinear growth of the peak power of SF pulses with increasing amplitude of injected current pulses and attribute it to cooperative pairing of electron-hole (e-h) radiative recombinations. The phase transitions from amplified spontaneous emission to superfluorescence and then to lasing regime is confirmed by observing (i) abrupt peak power growth accompanied by spectral broadening, (ii) spectral shape with hyperbolic secant envelope and (iii) red shift of central wavelength of SF emission pulse. The observed red shift of SF emission is shown to be caused by the pairing of e-h pairs in an indirect cooperative X-transition.
△ Less
Submitted 11 February, 2013; v1 submitted 1 February, 2013;
originally announced February 2013.
-
General-purpose and dedicated regimes in the use of telescopes
Authors:
Jerome Lamy,
Emmanuel Davoust
Abstract:
We propose a sociohistorical framework for better understanding the evolution in the use of telescopes. We define two regimes of use : a general-purpose (or survey) one, where the telescope governs research, and a dedicated one, in which the telescope is tailored to a specific project which includes a network of other tools. This conceptual framework is first applied to the history of the 80-cm…
▽ More
We propose a sociohistorical framework for better understanding the evolution in the use of telescopes. We define two regimes of use : a general-purpose (or survey) one, where the telescope governs research, and a dedicated one, in which the telescope is tailored to a specific project which includes a network of other tools. This conceptual framework is first applied to the history of the 80-cm telescope of Toulouse Observatory, which is initially anchored in a general-purpose regime linked to astrometry. After a transition in the 1930s, it is integrated in a dedicated regime centered on astrophysics. This evolution is compared to that of a very similar instrument, the 80-cm telescope of Marseille Observatory, which converts early on to the dedicated regime with the Fabry-Perot interferometer around 1910, and, after a period of idleness, is again used in the survey mode after WWII. To further validate our new concept, we apply it to the telescopes of Washburn Observatory, of Dominion Astrophysical Observatory and of Meudon Observatory. The uses of the different telescopes illustrate various combinations of the two regimes, which can be successive, simultaneous or alternating. This conceptual framework is likely to be applicable to other fields of pure and applied science.
△ Less
Submitted 18 May, 2009;
originally announced May 2009.
